Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
4.
Policy Polit Nurs Pract ; 22(1): 51-62, 2021 Feb.
Article in English | MEDLINE | ID: covidwho-883527

ABSTRACT

The state of American kidney health is currently under the microscope. In the United States, approximately 20,000 persons advance to end-stage renal disease annually. Trends indicate accelerating increases in cost of care and a high mortality rate among patients with end-stage renal disease, with only 57% of patients surviving after 3 years. An executive order by the White House has placed the transformation of kidney care at the forefront of the country's health care agenda. The order focuses on key issues including improving outcomes, reducing treatment-related expenditures and increasing kidney donations. Mobilization of health care resources directed toward policymaking, workforce growth and development, and research will be critical to effectively achieve this executive order. Nursing's response, as the health care profession with the most members, will be crucial to achieving response implementation and success of the order. This article describes immediate and future actions including policy, leadership, clinical, educational, and research initiatives that the nursing profession should take to advance kidney health. It calls for specific actions by nursing and focuses on nursing organizations, nursing research, quality improvement initiatives, nursing innovation, advanced practice nursing, and the nephrology and transplant nursing workforce in order to improve kidney health nationally. The impact of the SARS-CoV-2 pandemic on kidney health and the implications for the profession of nursing are outlined. Although there are still many unknowns about the pandemic, nursing's voice is necessary to ensure the ongoing delivery of high-quality care.


Subject(s)
Health Policy/legislation & jurisprudence , Kidney Failure, Chronic/nursing , Legislation, Nursing , Nurse's Role , Nursing Care/organization & administration , Quality of Health Care/legislation & jurisprudence , Quality of Health Care/organization & administration , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Organizational Objectives , United States
5.
Med Sci (Paris) ; 36(4): 303-307, 2020 Apr.
Article in French | MEDLINE | ID: covidwho-811536

ABSTRACT

TITLE: L'éthique des essais thérapeutiques. ABSTRACT: La pandémie de COVID-19 a conduit certains acteurs reconnus de la médecine à renoncer aux méthodes codifiées de la recherche médicale au profit d'affirmations établies dans l'urgence et sans réelle évaluation scientifique. Autant l'on peut comprendre que certains praticiens recourent à ce qui leur est ainsi proposé, autant cette confusion entre action dans l'urgence et recherche scientifique serait lourde de conséquences si elle venait à se généraliser, et cela à de multiples points de vue : image et rôle de la science, qualité et éthique de la recherche médicale et en fin de compte sort des malades soumis à des traitements mal évalués. Ce sont ces questions qui motivent la mise au point qui suit sur les questions d'éthique associées de longue date aux « essais thérapeutiques ¼, cette procédure rationnelle d'acquisition dans les meilleurs délais d'informations fiables sur les avantages et les risques des traitements dont on envisage l'éventuelle utilisation.


Subject(s)
Clinical Trials as Topic/ethics , Ethics, Medical , COVID-19 , Clinical Trials as Topic/legislation & jurisprudence , Coronavirus Infections/epidemiology , Coronavirus Infections/therapy , Emergency Medical Services/ethics , Emergency Medical Services/history , Emergency Medical Services/legislation & jurisprudence , Emergency Medical Services/methods , History, 21st Century , Humans , Informed Consent/ethics , Informed Consent/legislation & jurisprudence , Informed Consent/standards , Knowledge , Legislation, Medical , Pandemics , Pneumonia, Viral/epidemiology , Pneumonia, Viral/therapy , Quality Improvement , Quality of Health Care/ethics , Quality of Health Care/legislation & jurisprudence , Research Design/legislation & jurisprudence , Research Design/standards , Therapies, Investigational/ethics , Therapies, Investigational/standards
SELECTION OF CITATIONS
SEARCH DETAIL